LAURUS LABS Financial Statement Analysis
|
||
|
The Revenues of LAURUS LABS have increased by 2.54% YoY .
The Earnings Per Share (EPS) of LAURUS LABS has decreased by -5.45 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
LAURUS LABS Last 5 Annual Financial Results
[BOM: 540222|NSE : LAURUSLABS]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹4,936 Cr | ₹4,814 Cr | ₹2,832 Cr | ₹22,919 Cr | ₹2,056 Cr |
| Expenses | ₹3,513 Cr | ₹3,263 Cr | ₹2,267 Cr | ₹19,359 Cr | ₹1,643 Cr |
| Operating Profit (Excl OI) | ₹1,422 Cr | ₹1,551 Cr | ₹565 Cr | ₹3,560 Cr | ₹413 Cr |
| Other Income | ₹15 Cr | ₹24 Cr | ₹5.92 Cr | ₹162 Cr | ₹29 Cr |
| Interest | ₹102 Cr | ₹68 Cr | ₹90 Cr | ₹882 Cr | ₹80 Cr |
| Depreciation | ₹251 Cr | ₹205 Cr | ₹187 Cr | ₹1,642 Cr | ₹125 Cr |
| Profit Before Tax | ₹1,084 Cr | ₹1,301 Cr | ₹294 Cr | ₹1,198 Cr | ₹237 Cr |
| Profit After Tax | ₹832 Cr | ₹984 Cr | ₹255 Cr | ₹938 Cr | ₹168 Cr |
| Consolidated Net Profit | ₹828 Cr | ₹984 Cr | ₹255 Cr | ₹938 Cr | ₹168 Cr |
| Earnings Per Share (Rs) | ₹14.56 | ₹15.40 | ₹18.33 | ₹23.88 | ₹8.81 |
| PAT Margin (%) | 13.19 | 16.87 | 20.44 | 9.01 | 4.09 |
| ROE(%) | 21.63 | 28.05 | 45.15 | 15.39 | 6.19 |
| ROCE(%) | 22.97 | 25.97 | 39.82 | 14.14 | 8.22 |
| Total Debt/Equity(x) | 0.49 | 0.52 | 0.56 | 0.60 | 0.67 |
Key Financials |
||
| Market Cap | : | ₹ 23,899.3 Cr |
| Revenue (TTM) | : | ₹ 5,040.8 Cr |
| Net Profit(TTM) | : | ₹ 168.2 Cr |
| EPS (TTM) | : | ₹ 3.1 |
| P/E (TTM) | : | 142.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| LAURUS LABS | 2.4% | 11.6% | 47.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.6% | -4.7% | 54.7% |
| CIPLA | 4.4% | -4.4% | 54.7% |
| DR REDDYS LABORATORIES | 5.7% | 2.7% | 29.3% |
| ZYDUS LIFESCIENCES | 0.4% | -5.4% | 82.7% |
| DIVIS LABORATORIES | 5.8% | 17.7% | 24.8% |
| MANKIND PHARMA | -0.4% | 6% | NA |
| TORRENT PHARMACEUTICALS | 2% | 4.6% | 63.9% |
| LUPIN | 3.6% | 1.6% | 129.3% |
LAURUS LABS Revenues
[BOM: 540222|NSE : LAURUSLABS]
| Y-o-Y | 2.54 % |
| 5 Yr CAGR | 24.47 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹4,936 Cr | 2.54 | |
| Mar2022 | ₹4,814 Cr | 69.99 | |
| Mar2021 | ₹2,832 Cr | -87.64 | |
| Mar2020 | ₹22,919 Cr | 1,014.65 | |
| Mar2019 | ₹2,056 Cr | - | |
LAURUS LABS Operating Profit
[BOM: 540222|NSE : LAURUSLABS]
| Y-o-Y | -8.27 % |
| 5 Yr CAGR | 36.20 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹1,422 Cr | -8.27 | |
| Mar2022 | ₹1,551 Cr | 174.68 | |
| Mar2021 | ₹565 Cr | -84.14 | |
| Mar2020 | ₹3,560 Cr | 761.27 | |
| Mar2019 | ₹413 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -10.55 % |
| 5 Yr CAGR | 9.43 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 28.82% | -10.55 | |
| Mar2022 | 32.22% | 61.58 | |
| Mar2021 | 19.94% | 28.40 | |
| Mar2020 | 15.53% | -22.74 | |
| Mar2019 | 20.1% | - | |
LAURUS LABS Profit After Tax
[BOM: 540222|NSE : LAURUSLABS]
| Y-o-Y | -15.87 % |
| 5 Yr CAGR | 49.06 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹828 Cr | -15.87 | |
| Mar2022 | ₹984 Cr | 285.31 | |
| Mar2021 | ₹255 Cr | -72.78 | |
| Mar2020 | ₹938 Cr | 459.42 | |
| Mar2019 | ₹168 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -21.81 % |
| 5 Yr CAGR | 34.01 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 13.19 % | -21.81 | |
| Mar2022 | 16.87 % | -17.47 | |
| Mar2021 | 20.44 % | 126.86 | |
| Mar2020 | 9.01 % | 120.29 | |
| Mar2019 | 4.09 % | - | |
LAURUS LABS Earnings Per Share (EPS)
[BOM: 540222|NSE : LAURUSLABS]
| Y-o-Y | -5.45 % |
| 5 Yr CAGR | 13.38 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹15 | -5.45 | |
| Mar2022 | ₹15 | -15.98 | |
| Mar2021 | ₹18 | -23.24 | |
| Mar2020 | ₹24 | 171.06 | |
| Mar2019 | ₹8.81 | - | |
LAURUS LABS Return on Capital Employed (ROCE)
[BOM: 540222|NSE : LAURUSLABS]
| Y-o-Y | -11.55 % |
| 5 Yr CAGR | 29.29 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 22.97% | -11.55 | |
| Mar2022 | 25.97% | -34.78 | |
| Mar2021 | 39.82% | 181.61 | |
| Mar2020 | 14.14% | 72.02 | |
| Mar2019 | 8.22% | - | |
LAURUS LABS Share Price vs Sensex
| Current Share Price | : | ₹443.4 |
| Current MarketCap | : | ₹ 23,899.3 Cr |
| Updated EOD on | : | Apr 29,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 2.4% |
11.6% |
47.9% |
| SENSEX | 1.4% |
2.5% |
24.3% |
LAURUS LABS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE MID CAP | 3.8% | 8% | 67.9% |
| S&P BSE 150 MIDCAP | 3.4% | 7.9% | 60% |
| S&P BSE 400 MIDSMALLCAP | 3.3% | 8.8% | 61.9% |
| S&P BSE MIDSMALLCAP | 3.3% | 9.3% | 67.3% |
| S&P BSE HEALTHCARE | 2.2% | 3.1% | 56.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY FREE MIDCAP 100 | 3.5% | 7.4% | 62.9% |
| NIFTY MIDCAP150 | 3.4% | 7.7% | 60.6% |
| NIFTY MID SMALL400 | 3.3% | 9.1% | 64.6% |
| NIFTY HEALTHCARE | 2.5% | 1.6% | 52.8% |
| NIFTY LARGE MIDCAP 250 | 2.5% | 5.6% | 46.7% |
You may also like the below Video Courses
FAQ about LAURUS LABS Financials
How the annual revenues of LAURUS LABS have changed ?
The Revenues of LAURUS LABS have increased by 2.54% YoY .
How the Earnings per Share (EPS) of LAURUS LABS have changed?
The Earnings Per Share (EPS) of LAURUS LABS has decreased by -5.45 % YoY .
Check out Intrinsic Value of Peers of LAURUS LABS
Compare Stock Analytics of Peers of LAURUS LABS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
